Skip to content

Safety in Use Study.

Safety In-Use Study to Assess the Cutaneous Tolerance of Tear Free Baby body wash and Shampoo in Healthy Babies of 0 to 36 Months of Age.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/08/027020
Enrollment
36
Registered
2020-08-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Baby Wash and Shampoo: External Use Wet baby hair and body apply pea sized amount of the Baby Body wash and Shampoo generously gently working up a lather and rinse well Use once daily

Sponsors

Azafran Innovacion ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Babies in the age group of 0 (including new born full term babies Day 1) to 36 months (inclusive of both genders) at the time of consent 2 Babies general in good health as determined from a recent medical history 3 Babies mother or legal representative preferably mother willing to give a voluntary written parental informed consent and agree to come for regular follow up 4 Babies mother or legal representative preferably mother willing to abide by and comply with the study protocol 5 Babies should not participate in any other clinical study during participation in the current study

Exclusion criteria

Exclusion criteria: 1 Subjectââ?¬•s mother or legal caretaker not willing to stop the use of other baby body milk or lotion or cream or any other baby face or body moisturizing product during the study period 2 Chronic illness which may influence the cutaneous state 3 Subject on any systemic medication 4 Subject with birth defects and anomalies 5 Subject participating in a similar clinical study currently or during the previous 30 days 6 Any subject in the Investigators opinion not considered suitable for enrollment 7 A known history or present condition of allergic response to any other concern that may require medical attention 8 Babies with medical history (past present) of significant dermatological diseases or conditions such as atopy psoriasis vitiligo or other conditions known to alter skin appearance or physiologic response (eg.porphyria) chronic urticaria or sunburn rashes

Design outcomes

Primary

MeasureTime frame
1 The safety of the test product will be evaluated on the skin in terms of mildness, gentleness and non-irritability of babies� skin using pediatrician assessment 2 To determine the baby experienced no tear, provide quick clean, smooth and gentle effect on baby skin and hair and smooth and shiny hair by subjective self-assessment questionnaire from babies� mother/ legal caretaker Timepoint: 1. Day 01 Before application, Day 15 after application 2. Day 15 after application.

Secondary

MeasureTime frame
1 The effect of test product will be evaluated on improvement in the skin hydration using Corneometer�® CM 825 or Moisture Meter SCTimepoint: 1 Day 01 Before application, Day 15 after application.

Countries

India

Contacts

Public ContactMs Maheshvari Patel

Cliantha Research

nkpatel@cliantha.com9909013286

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026